Medica Corporation Recalls Capillary Tube Kits Due to Inaccurate Potassium Results
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medica Corporation has recalled 1,578 Capillary Tube Kits because of a defect causing falsely elevated potassium readings, which could lead to incorrect medical treatments.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references International. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Medica Corporation has initiated a voluntary recall of its capillary tubes used in EasyBloodGas and EasyStat kits. The recall was prompted by the discovery of a systematic positive bias of up to 20% across the reportable potassium range. This defect results in falsely elevated potassium readings for patient samples.
Which Products Are Affected
The recall involves 1,578 units of the following products:
- Product Name: Medica Capillary Tubes; EasyBloodGas/EasyStat Capillary Tube Kit
- Model Number: 7303
- UDI-DI: 00840095607575
- Lot Number: 25XXX
- Recall Number: Z-1370-2026
While the firm is based in Bedford, Massachusetts, the affected units were distributed internationally to Russia, Bulgaria, Kazakhstan, Ukraine, Pakistan, and Belarus.
What You Should Do
Medica Corporation initiated the recall notification via letter on December 31, 2025. Healthcare providers and distributors in possession of these kits should immediately follow the instructions provided in the notification letter from Medica Corporation. For inquiries, the company is located at 5 Oak Park Dr, Bedford, MA 01730.
Why This Matters
Inaccurate potassium measurements can lead to clinical misinterpretation and inappropriate medical interventions. A 20% positive bias poses a significant risk to patient safety by potentially masking true potassium levels or indicating hyperkalemia where it does not exist, leading to unnecessary or dangerous treatments.
Source
This information is based on official recall data provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.